Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 18 | 2023 | 1912 | 1.810 |
Why?
|
| Inflammatory Bowel Diseases | 9 | 2022 | 2425 | 1.230 |
Why?
|
| Feces | 5 | 2019 | 1402 | 0.740 |
Why?
|
| Tacrolimus | 1 | 2023 | 743 | 0.690 |
Why?
|
| Crohn Disease | 7 | 2022 | 2303 | 0.660 |
Why?
|
| Electric Power Supplies | 1 | 2018 | 99 | 0.600 |
Why?
|
| Antibodies, Fungal | 1 | 2017 | 32 | 0.590 |
Why?
|
| Levodopa | 1 | 2017 | 219 | 0.580 |
Why?
|
| Cholecalciferol | 1 | 2022 | 537 | 0.580 |
Why?
|
| Angelman Syndrome | 1 | 2017 | 136 | 0.530 |
Why?
|
| Mesalamine | 5 | 2022 | 136 | 0.440 |
Why?
|
| Clotrimazole | 3 | 2015 | 77 | 0.430 |
Why?
|
| Growth Disorders | 1 | 2016 | 645 | 0.380 |
Why?
|
| Iron | 1 | 2018 | 1774 | 0.360 |
Why?
|
| Gastrointestinal Agents | 4 | 2023 | 494 | 0.350 |
Why?
|
| Malnutrition | 1 | 2016 | 625 | 0.340 |
Why?
|
| Lactoferrin | 2 | 2007 | 97 | 0.340 |
Why?
|
| Anemia | 1 | 2018 | 1504 | 0.330 |
Why?
|
| Colectomy | 3 | 2023 | 683 | 0.320 |
Why?
|
| Infection Control | 1 | 2016 | 964 | 0.320 |
Why?
|
| Intestinal Mucosa | 6 | 2019 | 3036 | 0.290 |
Why?
|
| Chlorides | 3 | 2003 | 667 | 0.290 |
Why?
|
| Vaccines | 1 | 2016 | 822 | 0.290 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2007 | 104 | 0.270 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 2752 | 0.270 |
Why?
|
| Child | 24 | 2023 | 77679 | 0.260 |
Why?
|
| Abdominal Neoplasms | 1 | 2007 | 291 | 0.260 |
Why?
|
| Nelfinavir | 1 | 2003 | 68 | 0.240 |
Why?
|
| Anxiety | 1 | 2018 | 4297 | 0.230 |
Why?
|
| Environmental Exposure | 1 | 2017 | 4236 | 0.220 |
Why?
|
| Colon | 4 | 2021 | 1772 | 0.220 |
Why?
|
| Antifungal Agents | 2 | 1997 | 730 | 0.210 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2019 | 1854 | 0.210 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 311 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4419 | 0.210 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2019 | 2279 | 0.200 |
Why?
|
| Diarrhea | 4 | 2015 | 1347 | 0.200 |
Why?
|
| Dietary Supplements | 3 | 2022 | 3297 | 0.190 |
Why?
|
| Immunosuppressive Agents | 6 | 2022 | 4151 | 0.190 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 791 | 0.180 |
Why?
|
| Pancreatitis | 1 | 2007 | 1091 | 0.180 |
Why?
|
| Primary Health Care | 1 | 2016 | 4556 | 0.170 |
Why?
|
| Calcium Signaling | 1 | 2003 | 721 | 0.170 |
Why?
|
| Genes, Mitochondrial | 1 | 2019 | 61 | 0.170 |
Why?
|
| Child, Preschool | 11 | 2019 | 40992 | 0.160 |
Why?
|
| Neuroblastoma | 1 | 2007 | 1226 | 0.160 |
Why?
|
| Adolescent | 19 | 2022 | 85759 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 173 | 0.140 |
Why?
|
| Potassium | 2 | 1997 | 1336 | 0.140 |
Why?
|
| Rectum | 2 | 2019 | 904 | 0.140 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 288 | 0.140 |
Why?
|
| Colonoscopy | 3 | 2020 | 1367 | 0.140 |
Why?
|
| Long-Term Potentiation | 1 | 2017 | 293 | 0.140 |
Why?
|
| Antidiarrheals | 1 | 2015 | 45 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2022 | 9147 | 0.130 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 321 | 0.130 |
Why?
|
| Young Adult | 5 | 2023 | 56436 | 0.120 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 365 | 0.120 |
Why?
|
| Humans | 38 | 2023 | 744220 | 0.120 |
Why?
|
| Vitamin D | 2 | 2022 | 3222 | 0.120 |
Why?
|
| Enterocytes | 1 | 2015 | 225 | 0.120 |
Why?
|
| Alcohol-Related Disorders | 1 | 2016 | 234 | 0.120 |
Why?
|
| Treatment Outcome | 8 | 2023 | 63119 | 0.110 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2019 | 0.110 |
Why?
|
| Vitamins | 1 | 2022 | 1621 | 0.110 |
Why?
|
| Symporters | 1 | 2015 | 363 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2018 | 1533 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 1343 | 0.100 |
Why?
|
| ROC Curve | 2 | 2017 | 3527 | 0.100 |
Why?
|
| Mass Screening | 2 | 2019 | 5252 | 0.100 |
Why?
|
| Counseling | 1 | 2019 | 1523 | 0.100 |
Why?
|
| Eating | 1 | 2018 | 1538 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3871 | 0.100 |
Why?
|
| Intestines | 3 | 2008 | 1924 | 0.100 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 686 | 0.090 |
Why?
|
| Calcium | 3 | 2017 | 5757 | 0.090 |
Why?
|
| Calcium, Dietary | 1 | 2012 | 526 | 0.090 |
Why?
|
| Professional Competence | 1 | 2013 | 448 | 0.090 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 2008 | 12 | 0.080 |
Why?
|
| Integrin beta4 | 1 | 2008 | 31 | 0.080 |
Why?
|
| Nutrition Assessment | 1 | 2012 | 723 | 0.080 |
Why?
|
| Digestive System Abnormalities | 1 | 2008 | 52 | 0.080 |
Why?
|
| Pylorus | 1 | 2008 | 85 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2012 | 783 | 0.080 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2018 | 88 | 0.080 |
Why?
|
| Immunization | 1 | 2012 | 1256 | 0.080 |
Why?
|
| Enteritis | 1 | 2008 | 165 | 0.080 |
Why?
|
| Male | 19 | 2020 | 350027 | 0.070 |
Why?
|
| Endoscopy | 1 | 2017 | 1784 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2007 | 1789 | 0.070 |
Why?
|
| Female | 20 | 2020 | 380197 | 0.070 |
Why?
|
| Gastroenterology | 1 | 2013 | 536 | 0.070 |
Why?
|
| Physical Examination | 1 | 2012 | 1238 | 0.070 |
Why?
|
| HIV-1 | 1 | 2003 | 6938 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 391 | 0.070 |
Why?
|
| Severity of Illness Index | 7 | 2020 | 15538 | 0.070 |
Why?
|
| Capsule Endoscopy | 1 | 2007 | 125 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 13280 | 0.070 |
Why?
|
| Neoplasms | 1 | 2014 | 21672 | 0.060 |
Why?
|
| Nutrition Disorders | 1 | 2006 | 211 | 0.060 |
Why?
|
| Disease Management | 1 | 2016 | 2458 | 0.060 |
Why?
|
| Biological Transport | 4 | 2015 | 2120 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2017 | 25618 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 6991 | 0.060 |
Why?
|
| Potassium Channels | 2 | 1997 | 563 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21752 | 0.060 |
Why?
|
| Infant | 3 | 2017 | 35129 | 0.060 |
Why?
|
| Nutritional Support | 1 | 2005 | 168 | 0.060 |
Why?
|
| Cholera Toxin | 2 | 1997 | 556 | 0.060 |
Why?
|
| Colonic Diseases, Functional | 1 | 2003 | 38 | 0.060 |
Why?
|
| Colitis | 2 | 2017 | 1170 | 0.060 |
Why?
|
| Muscarinic Agonists | 1 | 2003 | 87 | 0.060 |
Why?
|
| Carbachol | 1 | 2003 | 226 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 3966 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2003 | 411 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 390 | 0.050 |
Why?
|
| Sulfasalazine | 1 | 2022 | 79 | 0.050 |
Why?
|
| Remission Induction | 2 | 2019 | 2389 | 0.050 |
Why?
|
| Probiotics | 1 | 2006 | 351 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2022 | 53280 | 0.050 |
Why?
|
| Azathioprine | 1 | 2022 | 355 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 814 | 0.050 |
Why?
|
| Incidence | 2 | 2017 | 20945 | 0.050 |
Why?
|
| Cytosol | 1 | 2003 | 901 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2003 | 3748 | 0.050 |
Why?
|
| Blood Sedimentation | 1 | 2020 | 231 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1791 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77426 | 0.040 |
Why?
|
| Cell Line | 4 | 2003 | 15999 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2007 | 1609 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18027 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 3086 | 0.040 |
Why?
|
| Porins | 1 | 2018 | 81 | 0.040 |
Why?
|
| Pediatrics | 1 | 2013 | 3469 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 8628 | 0.040 |
Why?
|
| Flagellin | 1 | 2018 | 125 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6386 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7179 | 0.040 |
Why?
|
| HIV Infections | 1 | 2003 | 16718 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 1997 | 171 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1584 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2021 | 40559 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17449 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 712 | 0.030 |
Why?
|
| Acute Disease | 1 | 2007 | 7148 | 0.030 |
Why?
|
| Radiography | 1 | 2007 | 7022 | 0.030 |
Why?
|
| Mice | 3 | 2017 | 81178 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1997 | 590 | 0.030 |
Why?
|
| Enterotoxins | 1 | 1997 | 368 | 0.030 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2015 | 47 | 0.030 |
Why?
|
| Chloride Channels | 1 | 1996 | 225 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 1996 | 346 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2015 | 98 | 0.030 |
Why?
|
| Epithelium | 2 | 1997 | 1680 | 0.030 |
Why?
|
| Time Factors | 4 | 2018 | 40063 | 0.030 |
Why?
|
| Integrins | 1 | 2019 | 846 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14726 | 0.030 |
Why?
|
| Diet | 1 | 2012 | 7937 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1194 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9438 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1997 | 772 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2015 | 315 | 0.030 |
Why?
|
| Jejunum | 1 | 2015 | 480 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1996 | 645 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1997 | 1907 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2017 | 542 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 933 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1471 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 2065 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 1997 | 931 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2015 | 593 | 0.020 |
Why?
|
| Rabbits | 1 | 1997 | 4892 | 0.020 |
Why?
|
| Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 168788 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3270 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12264 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2013 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 72280 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 1997 | 1053 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 3913 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2108 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1477 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2171 | 0.020 |
Why?
|
| Quality of Life | 2 | 2007 | 12805 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15070 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 23337 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6938 | 0.020 |
Why?
|
| Adult | 5 | 2019 | 214035 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.020 |
Why?
|
| Mitochondria | 1 | 2019 | 3520 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6757 | 0.020 |
Why?
|
| United States | 3 | 2018 | 69867 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.020 |
Why?
|
| Mutation | 1 | 2008 | 29784 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 650 | 0.010 |
Why?
|
| Signal Transduction | 2 | 1997 | 23404 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13990 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18367 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29050 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2013 | 3741 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1996 | 19227 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 10262 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 19907 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15525 | 0.010 |
Why?
|
| Inflammation | 1 | 2017 | 10634 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1988 | 2576 | 0.010 |
Why?
|
| Family | 1 | 1988 | 3148 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1997 | 682 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25043 | 0.010 |
Why?
|
| Skin | 1 | 2008 | 4363 | 0.010 |
Why?
|
| Endosomes | 1 | 1997 | 520 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1988 | 3336 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1456 | 0.010 |
Why?
|
| Middle Aged | 2 | 2003 | 213367 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1032 | 0.010 |
Why?
|
| Endocytosis | 1 | 1995 | 985 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 15226 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 5180 | 0.000 |
Why?
|
| Kinetics | 1 | 1995 | 6474 | 0.000 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 2867 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1988 | 2684 | 0.000 |
Why?
|
| Aged | 1 | 2003 | 163253 | 0.000 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_